These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15606554)

  • 1. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
    Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
    Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
    Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
    Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
    O'Donnell J; Tuddenham EG; Manning R; Kemball-Cook G; Johnson D; Laffan M
    Thromb Haemost; 1997 May; 77(5):825-8. PubMed ID: 9184386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial clustering of factor VIII and von Willebrand factor levels.
    Kamphuisen PW; Houwing-Duistermaat JJ; van Houwelingen HC; Eikenboom JC; Bertina RM; Rosendaal FR
    Thromb Haemost; 1998 Feb; 79(2):323-7. PubMed ID: 9493584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women.
    Marchetti G; Lunghi B; Legnani C; Cini M; Pinotti M; Mascoli F; Bernard F
    Haematologica; 2006 Sep; 91(9):1261-3. PubMed ID: 16956829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis.
    Favaloro EJ; Soltani S; McDonald J; Grezchnik E; Easton L; Favaloro JW
    Am J Clin Pathol; 2005 Dec; 124(6):910-7. PubMed ID: 16416741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.
    Mello TB; Siqueira LH; Montavão SA; Ozello MC; Annichino-Bizzacchi JM
    Thromb Res; 2008; 121(5):625-9. PubMed ID: 17889283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.
    Martinelli N; Girelli D; Ferraresi P; Olivieri O; Lunghi B; Manzato F; Corrocher R; Bernardi F
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):125-9. PubMed ID: 17287628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?
    Lwaleed BA; Greenfield R; Royle E; Birch B; Cooper AJ
    Int J Androl; 2005 Feb; 28(1):31-8. PubMed ID: 15679619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII expression in liver disease.
    Hollestelle MJ; Geertzen HG; Straatsburg IH; van Gulik TM; van Mourik JA
    Thromb Haemost; 2004 Feb; 91(2):267-75. PubMed ID: 14961153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality.
    Catto AJ; Carter AM; Barrett JH; Bamford J; Rice PJ; Grant PJ
    Thromb Haemost; 1997 Jun; 77(6):1104-8. PubMed ID: 9241740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.